Sei Investments Co. Increases Stake in IQVIA Holdings Inc. (NYSE:IQV)

Sei Investments Co. increased its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 4.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 86,503 shares of the medical research company’s stock after purchasing an additional 3,844 shares during the period. Sei Investments Co.’s holdings in IQVIA were worth $16,999,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in IQV. Intech Investment Management LLC bought a new position in IQVIA in the 3rd quarter valued at $223,000. Algert Global LLC purchased a new stake in shares of IQVIA during the third quarter valued at $514,000. Larson Financial Group LLC increased its stake in IQVIA by 745.1% in the 3rd quarter. Larson Financial Group LLC now owns 431 shares of the medical research company’s stock worth $102,000 after buying an additional 380 shares during the period. Fisher Asset Management LLC lifted its holdings in IQVIA by 4.8% during the 3rd quarter. Fisher Asset Management LLC now owns 7,398 shares of the medical research company’s stock valued at $1,753,000 after buying an additional 341 shares in the last quarter. Finally, Private Trust Co. NA boosted its position in IQVIA by 10.7% in the 3rd quarter. Private Trust Co. NA now owns 485 shares of the medical research company’s stock valued at $115,000 after buying an additional 47 shares during the period. 89.62% of the stock is currently owned by institutional investors.

IQVIA Stock Down 0.3 %

Shares of IQV opened at $179.40 on Friday. IQVIA Holdings Inc. has a 52-week low of $176.74 and a 52-week high of $253.84. The company has a market capitalization of $31.63 billion, a PE ratio of 23.92, a price-to-earnings-growth ratio of 1.99 and a beta of 1.50. The stock has a fifty day simple moving average of $193.55 and a two-hundred day simple moving average of $206.91. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 2.12.

IQVIA (NYSE:IQV) last posted its earnings results on Thursday, February 6th. The medical research company reported $2.90 EPS for the quarter, missing analysts’ consensus estimates of $3.11 by ($0.21). IQVIA had a net margin of 8.91% and a return on equity of 28.81%. As a group, equities analysts forecast that IQVIA Holdings Inc. will post 10.84 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on IQV shares. StockNews.com downgraded IQVIA from a “buy” rating to a “hold” rating in a report on Wednesday, March 12th. BTIG Research downgraded shares of IQVIA from a “buy” rating to a “neutral” rating in a research note on Monday, February 3rd. Stifel Nicolaus reduced their price objective on shares of IQVIA from $273.00 to $261.00 and set a “buy” rating for the company in a research note on Friday, February 7th. Stephens began coverage on IQVIA in a research report on Friday, December 20th. They set an “overweight” rating and a $250.00 target price on the stock. Finally, Truist Financial reissued a “buy” rating and issued a $263.00 price target (up from $261.00) on shares of IQVIA in a research report on Monday, February 10th. Five analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $249.05.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.